| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |